# OnCo record sutro-biopharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/sutro-biopharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "sutro-biopharma" ;
  schema:name "Sutro Biopharma"@en ;
  schema:description "Cell-free protein synthesis ADC company that refocused on exatecan and dual-payload ADCs, deprioritising its folate-receptor ADC luveltamab."@en ;
  schema:url <https://onco.cc/companies/sutro-biopharma/>, <https://www.sutrobio.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.biospace.com/press-releases/sutro-biopharma-presents-promising-preclinical-data-across-its-pipeline-of-next-generation-single-and-dual-payload-adc-programs-at-aacr-2026> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/dual-payload-adc/>, <https://onco.cc/technologies/site-specific-conjugation/> ;
  onco:targets <https://onco.cc/targets/tissue-factor/>, <https://onco.cc/targets/folr1/> .